Earnings roundup: AbbVie angst, a bifurcated vaccine market and Bristol Myers’ waiting game

Vaccine makers are seeing sales declines in the U.S. and upswings in Europe. Elsewhere, investors fretted over an AbbVie franchise and Bristol Myers pointed to a trio of narrative-changing trials.

Continue reading →